Full Text
PSS2 USE OF INCREASED DOSAGES OF BIOLOGICS IN PLAQUE PSORIASIS AND POTENTIAL SAVINGS BY TREATING HIGH-DOSE PATIENTS WITH USTEKINUMAB INSTEAD-A BUDGET IMPACT MODEL

Abstract

Authors

M Klesse F Wolbring

Back to Volume 13, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×